📊 Get daily AI-graded market briefings
Morning + evening · AI impact + sector exposure · Free
LAST 30 DAYS
1 articles
AVG GRADE
NEUTRAL
score: 0.00
SENTIMENT
BULLISH
TOTAL VIEWS
5
RECENT COVERAGE · 2 ARTICLES
AC Immune Reports Interim Phase 1b/2 Data For Alzheimer's Candidate ACI-24; Stock Down In Pre-market
AC Immune disclosed interim Phase 1b/2 efficacy and safety data for ACI-24, its anti-amyloid beta immunotherapy targeting prodromal...
AC Immune to Receive Research Grant from Goradia Family for Development of ACI-7104 in Parkinson’s Disease
ACIU announced receipt of a research grant from the Goradia Family to advance development of ACI-7104, a therapeutic candidate targeting...
E
ESEN Analytics
AI-powered equity research platform covering 5,000+ US equities. Our proprietary AI grading system (A+ to D scale) analyzes fundamentals, technicals, and news sentiment daily. Coverage data updated every 24 hours.
Learn about our methodology →
ⓘ AI-graded news coverage · Not investment advice